{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:09:00Z","timestamp":1778548140154,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:00:00Z","timestamp":1793059200000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016056"],"award-info":[{"award-number":["P30 CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.modpat.2025.100902","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:21:56Z","timestamp":1759339316000},"page":"100902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predicting the Probability of Residual Axillary Nodal Metastases in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8112-6590","authenticated-orcid":false,"given":"Thaer","family":"Khoury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fareed","family":"Rajack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangwei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janie","family":"Theriot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Bragiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.modpat.2025.100902_bib1","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","article-title":"Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements","volume":"26","author":"McLaughlin","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9069","key":"10.1016\/j.modpat.2025.100902_bib2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0140-6736(97)01004-0","article-title":"Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes","volume":"349","author":"Veronesi","year":"1997","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.modpat.2025.100902_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJM199810013391401","article-title":"The sentinel node in breast cancer--a multicenter validation study","volume":"339","author":"Krag","year":"1998","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.modpat.2025.100902_bib4","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","article-title":"A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy","volume":"10","author":"Van Zee","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100902_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/SLA.0b013e318238f461","article-title":"Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node","volume":"255","author":"Mittendorf","year":"2012","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.modpat.2025.100902_bib6","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2025.100902_bib7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.modpat.2025.100902_bib8","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"13","key":"10.1016\/j.modpat.2025.100902_bib9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2313487","article-title":"Omitting axillary dissection in breast cancer with sentinel-node metastases","volume":"390","author":"de Boniface","year":"2024","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.modpat.2025.100902_bib10","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1200\/JCO.22.00519","article-title":"Systemic therapy for advanced human epidermal growth factor receptor 2-positive breast cancer: ASCO guideline update","volume":"40","author":"Giordano","year":"2022","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100902_bib11","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.modpat.2025.100902_bib12","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.modpat.2025.100902_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(17)30777-5","article-title":"Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials","volume":"19","year":"2018","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100902_bib14","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1245\/s10434-017-6016-y","article-title":"The optimal treatment plan to avoid axillary lymph node dissection in early-stage breast cancer patients differs by surgical strategy and tumor subtype","volume":"24","author":"Pilewskie","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100902_bib17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1245\/s10434-024-16472-6","article-title":"Breast cancer recurrence in initially clinically node-positive patients undergoing sentinel lymph node biopsy after neoadjuvant chemotherapy in the NEOSENTITURK-trials MF18-02\/18-03","volume":"32","author":"Cabioglu","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100902_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s12957-024-03547-7","article-title":"Axillary lymph node dissection is not required for breast cancer patients with minimal axillary residual disease after neoadjuvant chemotherapy","volume":"22","author":"Muslumanoglu","year":"2024","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.modpat.2025.100902_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2024.102062","article-title":"De-escalating axillary management after neoadjuvant chemotherapy in breast cancer: the ratio of positive sentinel lymph nodes matters","volume":"54","author":"Arag\u00f3n-S\u00e1nchez","year":"2024","journal-title":"Surg Oncol"},{"issue":"21","key":"10.1016\/j.modpat.2025.100902_bib20","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.3390\/cancers16213638","article-title":"Predicting additional metastases in axillary lymph node dissection after neoadjuvant chemotherapy: ratio of positive\/total sentinel nodes","volume":"16","author":"Cebrecos","year":"2024","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.modpat.2025.100902_bib21","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1245\/s10434-024-15354-1","article-title":"Residual axillary metastases in node-positive breast cancer patients after neoadjuvant treatment: a register-based study","volume":"31","author":"Munck","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100902_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jso.25989","article-title":"A nomogram to predict non\u2013sentinel lymph node metastasis in patients with initial cN+ breast cancer that downstages to cN0 after neoadjuvant chemotherapy","volume":"122","author":"Cheng","year":"2020","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.modpat.2025.100902_bib23","series-title":"AJCC Cancer Staging Manual","first-page":"589","article-title":"Breast","author":"Hortobagyi GN CJ","year":"2017"},{"issue":"28","key":"10.1016\/j.modpat.2025.100902_bib24","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1200\/JCO.2007.10.6823","article-title":"Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy","volume":"25","author":"Symmans","year":"2007","journal-title":"J Clin Oncol"},{"issue":"9816","key":"10.1016\/j.modpat.2025.100902_bib25","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(11)61847-3","article-title":"Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial","volume":"379","author":"Baselga","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.modpat.2025.100902_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.modpat.2025.100902_bib27","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.modpat.2025.100902_bib28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100902_bib29","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1158\/1078-0432.CCR-19-3492","article-title":"Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis","volume":"26","author":"Spring","year":"2020","journal-title":"Clin Cancer Res"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225002005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225002005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:13:45Z","timestamp":1778544825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395225002005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0893395225002005"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100902","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the Probability of Residual Axillary Nodal Metastases in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100902","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100902"}}